Editor's Note: Green and red arrows refer to intraday stock price movement.
NEW YORK (
CHANGE IN RATINGS
downgraded at BMO to Underperform, BMO Capital said. $15 price target. Company's cash flow is disappointing.
Abercrombie & Fitch
downgraded at Argus from Buy to Hold, Argus Research said. Valuation call.
downgraded at Sterne Agee from Buy to Neutral, Sterne Agee said. Valuation call, based on a $60 price target.
upgraded at BofA/Merrill from Neutral to Buy, Bank of America/Merrill Lynch said. $89 price target. Expect better growth from the company's MS drug.
rated new Outperform at JMP Securities. $21 price target. Company is market leader and posting better returns.
CB Richard Ellis Group
upgraded at BofA/Merrill to Buy from Neutral as lending standards should support increasing transaction volumes in 2011 and 2012, Bank of America/Merrill Lynch said. Price target lifted to $32.
rated new Buy at Sterne Agee. $52 price target. Company is underfollowed and in the midst of a turnaround.
upgraded at ThinkEquity from Hold to Buy, ThinkEquity said. $37 price target. Tighter discrete market should help near-term results.
upgraded at BofA/Merrill to Buy. $43 price target. California regulatory environment remains favorable.
upgraded at BofA/Merrill to Buy from Neutral. Favorable regulation environment, compelling utility story, and valuation, Bank of America/Merrill Lynch said. Price target raised to $43.
rated new Overweight at Morgan Stanley. $71 price target. Expect more rate-led sales growth in the coming quarters.
Jones Lang LaSalle
upgraded at BofA/Merrill to Buy from Neutral given that US commercial real estate lending standards have peaked, Bank of America/Merrill Lynch said. Price target boosted to $120 from $100.
Level 3 Communications
upgraded at UBS from Sell to Neutral, UBS said. $1.60 price target. Expect significant synergies from the GLBC deal.
rated new Equal-weight at Morgan Stanley. Valuation call, based on a $38 price target.
rated new Neutral at Baird. Valuation call, based on a $30 price target.
rated new Outperform at Wells Fargo. Company is positioned well for the next industry cycle.
numbers lowered at Goldman. WMS estimates were cut through 2013, Goldman Sachs said. Company lowered its guidance. Sell rating and new $27 price target.
downgraded at Jefferies from Buy to Hold, Jefferies said. Company appears to be facing its own challenges, on top of slower industry demand. $36 price target.
End of report.
This article was written by a staff member of TheStreet.